New and Integrated Approaches to Successful Accelerated Drug Development

  • 16 Citations


Traditionally, the development of a new drug from discovery to market takes 10 to 15 years and costs hundreds of millions of dollars. Accelerated drug development, therefore, is of critical importance to both maximizing return on this investment and bringing drugs for unmet medical needs to patients as rapidly as possible. New structure-based development strategies are being combined with integrated, multidisciplinary approaches to speed the processes of physicochemical and pharmacological characterization, toxico-logical investigation, and clinical testing. The process of accelerated drug development, however, presents unique challenges as well as opportunities.

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Subscribe to journal

Immediate online access to all issues from 2019. Subscription will auto renew annually.

US$ 189

This is the net price. Taxes to be calculated in checkout.


  1. 1.

    DeMasi JA. Trends in drug development: costs, times, and risks. Drug Inf J. 1995;29:375–384.

  2. 2.

    Lin JH, Lu AY. Role of pharmacokinetics and metabolism in drug discovery and development. Pharmacol Rev. 1997;49:403–449.

  3. 3.

    DeMasi JA, Hansen RW, Grabowski HG, Lasagna L. Research and development costs for new drugs by therapeutic category. Pharma Econ. 1995;7:152–169.

  4. 4.

    Kleinberg ML, Wanke LA. New approaches and technologies in drug design and discovery. Am J Health SystPharm. 1995;52:1323–1336;1341–1343.

  5. 5.

    Andersen Consulting. Pharmaceutical & Medical Products Executive Briefing. Drug Discovery: Innovation and Productivity. 1998:1–26.

  6. 6.

    Bugg CE, Carson WM, Montgomery JA. Drugs by design. Sci Am. 1993;269:92–98.

  7. 7.

    Ziai MR, Beer B. Making business sense of science with rational drug design. Pharm Exec. 1990;10:40, 42, 44, 46.

  8. 8.

    Hayes AH, Jr. Safety considerations in product development. Drug Saf. 1990;5(suppl):24–26.

  9. 9.

    Establishment of Prescription Drug User Fee Rates for Fiscal Year 1998. Federal Register. 1997;62(236):64849–64851.

Download references

Author information

Correspondence to Anthony Clemento MA.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Clemento, A. New and Integrated Approaches to Successful Accelerated Drug Development. Ther Innov Regul Sci 33, 699–710 (1999) doi:10.1177/009286159903300306

Download citation

Key Words

  • Clinical testing
  • Accelerated drug development
  • Drug discovery
  • Preclinical testing
  • Product development
  • Research